Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.

Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.

Item
http://www.wikidata.org/entity/Q33380959
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionTargeted immunotherapy for acute myeloid leukemiaRecombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemiaChemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maDepletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).Immunotherapy prospects for acute myeloid leukaemia.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects.Targeting neoantigens to augment antitumour immunity.
P2860

Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.

Item
http://www.wikidata.org/entity/Q33380959
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Low dose interleukin-2 followi ...... a in first complete remission.
@ast
Low dose interleukin-2 followi ...... a in first complete remission.
@en
type
label
Low dose interleukin-2 followi ...... a in first complete remission.
@ast
Low dose interleukin-2 followi ...... a in first complete remission.
@en
prefLabel
Low dose interleukin-2 followi ...... a in first complete remission.
@ast
Low dose interleukin-2 followi ...... a in first complete remission.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Low dose interleukin-2 followi ...... a in first complete remission.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921